JP Morgan Healthcare Day Two: Thermo Fisher; Qiagen; Danaher; Counsyl; Human Longevity; Adaptive Bio, 10X Genomics and Pacific Biosciences

Feeds:: Posts; Comments

at #JPM16 – Moderna Therapeutics turns away an extra $200 million: with AstraZeneca (collaboration) & with Merck ($100 million investment) »

JP Morgan Healthcare Day Two: Thermo Fisher; Qiagen; Danaher; Counsyl; Human Longevity; Adaptive Bio, 10X Genomics and Pacific Biosciences

January 13, 2016 by 2012pharmaceutical

JP Morgan Healthcare Day Two: Thermo Fisher; Qiagen; Danaher; Counsyl; Human Longevity; Adaptive Bio, 10X Genomics and Pacific Biosciences

Reporter: Aviva Lev-Ari, PhD, RN

JPM16 & BTS16: A dour start to biopharma’s big week as stocks feel the pain

By Sy Mukherjee | January 12, 2016

BioPharma Dive is here in San Francisco attending the Biotech Showcase 2016 and the 34th Annual JPMorgan Healthcare Conference. The city is swamped with biopharma companies, healthcare firms, investors & VCs, and analysts of all stripes for what has grown to be the biggest week for the life sciences.

But unlike last year, when the industry’s bullishness about 2015 was palpable, the conferences this year got off to a decidedly more downbeat start on Monday. Here are the topline takeaways you need to know from yesterday’s events and presentations.

Biopharma stocks continue to feel the New Year pain

GENOMICS in Focus

JP Morgan Healthcare Day Two: Thermo Fisher; Qiagen; Danaher; Counsyl; Human Longevity; Adaptive Bio, 10X Genomics, Pacific Biosciences

Reporters: Staff Reporter @ genomeweb.com

JP Morgan Healthcare Day Two: Thermo Fisher; Qiagen; Danaher; Counsyl; Human Longevity; Adaptive Bio, 10X Genomics, Pacific Biosciences

Jan 13, 2016

Ed Winnick

Monica Heger

the_westin_st._francis_hotel_san_francisco.jpg

Westin St. Francis Hotel, San Francisco, site of the JP Morgan Healthcare Conference Westin St. Francis Hotel, San Francisco, site of the JP Morgan Healthcare Conference

WikiMedia Commons

SAN FRANCISCO (GenomeWeb) – The 34th Annual JP Morgan Healthcare Conference entered its second day here Tuesday with several life science research tools and diagnostic firms making presentations to investors and other attendees.

The following are capsules from the presentations and breakout sessions of

Thermo Fisher Scientific,
Qiagen,
Danaher,
Counsyl,
Human Longevity, and
Adaptive Biotechnologies.

SEE DETAILS in

SOURCE

https://www.genomeweb.com/business-news/jp-morgan-healthcare-day-two-thermo-fisher-qiagen-danaher-counsyl-human-longevity

10X Genomics, Pacific Biosciences Provide Business Updates at JP Morgan Healthcare Conference

Jan 13, 2016

Monica Heger

Among the presenting companies were sequencing technology firms 10X Genomics and Pacific Biosciences. Executives from these firms provided attendees with an update on recently launched products and platforms, and future technology developments.